GKB Ophthalmics
Healthcare
GKB NSE
₹61.78 −0.81 (−1.29%)
- P/E
- Not meaningful: loss-making over the last twelve months
Close 4 Nov 2026 ₹61.78 −3.23 −4.97% 1Y
Start ₹65.01
Key Fundamentals
MicrocapHealthcare Equipment & SuppliesHealthcarePrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 0.47%
- Debt to Equity
- 0.67
- EPS (TTM)
- −₹3.81
- Book Value
- ₹104.82
- Market Cap
- —
- P/E (TTM)
- Not meaningful: loss-making over the last twelve months
- P/B
- 0.59
- ROE
- −12.20%
- Dividend Yield
- 0.00%
- EBITDA
- ₹10.90 Cr
- 52W High
- ₹76.90
- 52W Low
- ₹45.25
- Day Range
- ₹60.11 – ₹62.90
- Volume
- 934
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
45 Average
Data confidence 93/100
Category scores
- Quality
- 39
- Weak
- Returns, margins, earnings quality 22% weight
- Valuation
- 61
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 9
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 26
- Poor
- Solvency, leverage, coverage 9% weight
- Momentum
- 51
- Average
- Trend strength, vol-adjusted 12% weight
- Ownership
- 50
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company has reduced debt.
Weaknesses
5- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of 3.74% over past five years.
- Company has a low return on equity of -18.5% over last 3 years.
- Earnings include an other income of Rs.4.58 Cr.
- Company's cost of borrowing seems high
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 7 | 6 | 6 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Neutral | 5 | 0 | 5 |
Oscillators
Bearish
Bearish
2
Neutral
6
Bullish
1
Overall
Bearish
Bearish
7
Neutral
6
Bullish
6
Moving Averages
Neutral
Bearish
5
Neutral
0
Bullish
5
Key readings
- RSI (14)
- 49.80
- Neutral
- MACD (12,26,9)
- −0.83
- Bullish
- SMA (50)
- 63.80
- Bearish
- SMA (200)
- 61.22
- Bullish
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | −1.93% |
|---|---|
| 5Y | +3.74% |
| 3Y | −2.58% |
| 1Y | −21.71% |
| TTM | −29.29% |
Net profit
| 10Y | Turned to loss |
|---|---|
| 5Y | Loss widened by ₹1.46 Cr |
| 3Y | Loss widened by ₹0.69 Cr |
| 1Y | Loss narrowed by ₹2.54 Cr |
| TTM | Loss narrowed by ₹4.92 Cr |
Operating cash flow
| 10Y | Outflow narrowed by ₹10.42 Cr |
|---|---|
| 5Y | Turned negative |
| 3Y | Outflow widened by ₹0.34 Cr |
| 1Y | Outflow narrowed by ₹3.56 Cr |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −3.75 pp |
|---|---|
| 5Y | −10.22 pp |
| 3Y | −7.65 pp |
| 1Y | −0.98 pp |
| TTM | +1.59 pp |
Revenue by year
| Mar 2017 | ₹40.65 Cr |
|---|---|
| Mar 2018 | ₹37.43 Cr |
| Mar 2019 | ₹30.47 Cr |
| Mar 2020 | ₹25.56 Cr |
| Mar 2021 | ₹21.34 Cr |
| Mar 2022 | ₹27.05 Cr |
| Mar 2023 | ₹27.73 Cr |
| Mar 2024 | ₹31.18 Cr |
| Mar 2025 | ₹32.75 Cr |
| Mar 2026 | ₹25.64 Cr |
Net profit by year
| Mar 2017 | ₹0.76 Cr |
|---|---|
| Mar 2018 | −₹2.58 Cr |
| Mar 2019 | −₹2.78 Cr |
| Mar 2020 | −₹4.17 Cr |
| Mar 2021 | −₹2.11 Cr |
| Mar 2022 | −₹2.31 Cr |
| Mar 2023 | −₹2.88 Cr |
| Mar 2024 | −₹3.42 Cr |
| Mar 2025 | −₹6.11 Cr |
| Mar 2026 | −₹3.57 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 9.71 | 7.27 | 6.84 | 7.36 | 8.62 | 8.26 | 7.45 | 8.43 | 8.77 | 6.11 | 4.36 | 6.4 | 6.4 |
| Expenses | 8.72 | 8.12 | 7.85 | 7.77 | 9.05 | 9.3 | 8.27 | 9.61 | 9.62 | 6.74 | 5.41 | 6.85 | 6.65 |
| Operating Profit | 0.99 | −0.85 | −1.01 | −0.41 | −0.43 | −1.04 | −0.82 | −1.18 | −0.85 | −0.63 | −1.05 | −0.45 | −0.25 |
| OPM % | 10.2% | −11.69% | −14.77% | −5.57% | −4.99% | −12.59% | −11.01% | −14% | −9.69% | −10.31% | −24.08% | −7.03% | −3.91% |
| Other Income | 0.09 | 0.07 | 1.72 | 0.2 | 0.09 | 0.06 | 1.81 | 0.01 | 0.07 | 1.37 | 3.24 | −0.5 | 0.47 |
| Interest | 0.37 | 0.38 | 0.36 | 0.48 | 0.41 | 0.4 | 0.48 | 0.6 | 0.68 | 0.57 | 0.6 | 0.32 | 0.3 |
| Depreciation | 0.64 | 0.65 | 0.66 | 0.64 | 0.65 | 0.66 | 0.67 | 0.66 | 0.67 | 0.68 | 0.68 | 0.66 | 0.66 |
| PBT | 0.07 | −1.81 | −0.31 | −1.33 | −1.4 | −2.04 | −0.16 | −2.43 | −2.13 | −0.51 | 0.91 | −1.93 | −0.74 |
| Tax % | 0% | 0% | 0% | 3.01% | 0.71% | 0.49% | 6.25% | 1.65% | 0.94% | 3.92% | −7.69% | −2.07% | −32.43% |
| Net Profit | 0.08 | −1.81 | −0.31 | −1.37 | −1.41 | −2.05 | −0.17 | −2.48 | −2.14 | −0.52 | 0.98 | −1.88 | −0.5 |
| EPS (₹) | 0.16 | −3.59 | −0.62 | −2.72 | −2.8 | −4.07 | −0.34 | −4.92 | −4.25 | −1.03 | 1.94 | −3.73 | −0.99 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 29.85 | 31.17 | 40.65 | 37.43 | 30.47 | 25.56 | 21.34 | 27.05 | 27.73 | 31.18 | 32.75 | 25.64 | 23.27 |
| Expenses | 30.63 | 33.61 | 41.05 | 38.41 | 31.52 | 26.29 | 21.63 | 27.44 | 28.82 | 32.46 | 36.22 | 28.61 | 25.65 |
| Operating Profit | −0.78 | −2.44 | −0.4 | −0.98 | −1.05 | −0.73 | −0.29 | −0.39 | −1.09 | −1.28 | −3.47 | −2.97 | −2.38 |
| OPM % | −2.61% | −7.83% | −0.98% | −2.62% | −3.45% | −2.86% | −1.36% | −1.44% | −3.93% | −4.11% | −10.6% | −11.58% | −10.23% |
| Other Income | 1.72 | 23.08 | 4.11 | 1.05 | 2.62 | 1.38 | 2.33 | 1.91 | 2.09 | 2.08 | 1.97 | 4.18 | 4.58 |
| Interest | 2.49 | 1.61 | 1.26 | 1.23 | 1.39 | 1.35 | 1.34 | 1.34 | 1.5 | 1.59 | 1.89 | 2.17 | 1.79 |
| Depreciation | 1.48 | 1.42 | 1.34 | 1.58 | 3.43 | 3.47 | 2.99 | 2.49 | 2.54 | 2.59 | 2.64 | 2.69 | 2.68 |
| PBT | −3.03 | 17.61 | 1.11 | −2.74 | −3.25 | −4.17 | −2.29 | −2.31 | −3.04 | −3.38 | −6.03 | −3.65 | −2.27 |
| Tax % | −25.41% | 22.43% | 31.53% | −6.2% | −14.77% | 0% | −7.86% | 0% | −5.26% | 1.18% | 1.16% | −2.19% | — |
| Net Profit | −2.26 | 13.66 | 0.76 | −2.58 | −2.78 | −4.17 | −2.11 | −2.31 | −2.88 | −3.42 | −6.11 | −3.57 | −1.92 |
| EPS (₹) | −5.44 | 32.89 | 1.83 | −6.21 | −5.99 | −8.27 | −4.19 | −4.58 | −5.71 | −6.78 | −12.12 | −7.08 | −3.81 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.15 | 4.15 | 4.15 | 4.15 | 4.64 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 | 5.04 |
| Reserves | 11.14 | 24.8 | 25.44 | 22.78 | 30.03 | 30.21 | 27.73 | 25.36 | 22.48 | 18.95 | 12.63 | 9.28 |
| Borrowings | 8.62 | 7.22 | 7.19 | 9.93 | 10.05 | 10.04 | 11.97 | 11.75 | 11.22 | 11.08 | 18.09 | 9.54 |
| Other Liabilities | 24.79 | 11.36 | 10.22 | 8.57 | 10.45 | 11.4 | 12.13 | 11.74 | 10.41 | 13.32 | 13.72 | 12.75 |
| Total Liabilities | 48.7 | 47.53 | 47 | 45.43 | 55.17 | 56.69 | 56.87 | 53.89 | 49.15 | 48.39 | 49.48 | 36.61 |
| Fixed Assets | 11.72 | 12.49 | 16.43 | 16.98 | 24.29 | 24.83 | 22.28 | 21.27 | 17.28 | 15.89 | 14.44 | 12.49 |
| CWIP | 0.57 | 0.57 | 0.57 | 0.24 | 0 | 0 | 1.23 | 3.29 | 3.82 | 3.78 | 3.78 | 3.78 |
| Investments | 5.53 | 10.45 | 3.77 | 0.66 | 0.32 | 3.21 | 12.22 | 11.9 | 11.9 | 11.9 | 11.9 | 0.19 |
| Other Assets | 30.88 | 24.02 | 26.23 | 27.55 | 30.56 | 28.65 | 21.14 | 17.43 | 16.15 | 16.82 | 19.36 | 20.15 |
| Total Assets | 48.7 | 47.53 | 47 | 45.43 | 55.17 | 56.69 | 56.87 | 53.89 | 49.15 | 48.39 | 49.48 | 36.61 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 5.87 | −11.9 | −4.2 | −3.71 | 5.31 | 6.13 | 2.11 | 2.33 | −1.14 | 1.36 | −5.04 | −1.48 |
| Investing | 0.13 | 14.74 | 5.5 | 2.28 | −8.63 | −5.68 | −11.52 | −0.83 | 2.4 | 0.37 | −0.16 | 12.21 |
| Financing | −6 | −2.81 | −1.29 | 1.41 | 9.21 | 3.31 | 0.61 | −1.5 | −2.03 | −1.74 | 5.12 | −10.72 |
| Net Cash Flow | 0 | 0.02 | 0 | −0.02 | 5.88 | 3.76 | −8.8 | 0 | −0.78 | 0 | −0.07 | 0 |
| Free Cash Flow | 5.24 | −13.83 | −9.08 | −5.27 | −4.35 | 2.44 | −1.2 | −1.34 | 0.25 | 0.16 | −6.43 | −2.06 |
| CFO/OP | −1,028 | 202 | 725 | 366 | −509 | −841 | −728 | −600 | 101 | −107 | 144 | 49 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 177 | 92.63 | 66 | 102 | 129 | 148 | 127 | 80.96 | 64.23 | 80.3 | 83.48 | 73.74 |
| Inventory Days | 351 | 285 | 284 | 264 | 155 | 134 | 257 | 142 | 162 | 102 | 120 | 143 |
| Days Payable | 362 | 120 | 107 | 84.89 | 171 | 223 | 251 | 159 | 139 | 158 | 138 | 139 |
| Cash Conversion Cycle | 165 | 258 | 243 | 281 | 113 | 58.61 | 133 | 63.96 | 86.93 | 24.86 | 65.88 | 77.61 |
| Working Capital Days | −21.15 | 69.79 | 80.72 | 94.59 | −7.67 | −56.12 | −86.38 | −85.68 | −60.02 | −85.22 | −70.1 | −34.17 |
| ROCE % | −3.86% | −6.26% | −0.77% | −4.13% | −8.09% | −6.29% | 0.13% | −2.14% | −3.96% | −4.96% | −11.8% | 0.47% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view GKB Ophthalmics insights
29 extracted metrics across FY15–FY27.
Documents
- 4 Jun 2026
- 26 May 2026
- 23 Dec 2025
- 9 Apr 2025
- 25 Jan 2024
- General announcements 8 Oct 2026
- General announcements 22 Sep 2026
Frequently Asked Questions about GKB Ophthalmics
What does GKB Ophthalmics Ltd do?
Incorporated in 1981, GKB Ophthalmics Ltd is engaged in the manufacture and sale of ophthalmic lenses made up of Glass and Plastic.
Where is GKB Ophthalmics Ltd (GKB) listed?
GKB Ophthalmics Ltd trades as GKB on the NSE and under code 533212 on the BSE.
Which sector does GKB Ophthalmics Ltd belong to?
GKB Ophthalmics Ltd is classified under the Healthcare sector, in the Medical Equipment industry.
What is the 52-week high and low of GKB Ophthalmics Ltd?
Over the last 52 weeks GKB Ophthalmics Ltd has traded between ₹45.25 and ₹76.9 as of 4 Nov 2026.
What is the Return on Equity (ROE) of GKB Ophthalmics Ltd?
GKB Ophthalmics Ltd reported a return on equity of -12.20%. Its debt-to-equity ratio is 0.67.
Company Information
Incorporated in 1981, GKB Ophthalmics Ltd is engaged in the manufacture and sale of ophthalmic lenses made up of Glass and Plastic.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/533212.md for GKB Ophthalmics Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.